| Evaluation of Genetic Mutations Associated with Mycobacterium tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review SB Georghiou, M Magana, RS Garfein, DG Catanzaro, A Catanzaro, ... PloS one 7 (3), e33275, 2012 | 330 | 2012 |
| Rapid drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates directly from clinical samples by use of amplicon sequencing: a proof-of-concept study RE Colman, J Anderson, D Lemmer, E Lehmkuhl, SB Georghiou, ... Journal of clinical microbiology 54 (8), 2058-2067, 2016 | 108 | 2016 |
| Bacillus thuringiensis Cry5B Protein Is Highly Efficacious as a Single-Dose Therapy against an Intestinal Roundworm Infection in Mice Y Hu, SB Georghiou, AJ Kelleher, RV Aroian PLoS neglected tropical diseases 4 (3), e614, 2010 | 89 | 2010 |
| Xpert MTB/XDR: a 10-color reflex assay suitable for point-of-care settings to detect isoniazid, fluoroquinolone, and second-line-injectable-drug resistance directly from … Y Cao, H Parmar, RL Gaur, D Lieu, S Raghunath, N Via, S Battaglia, ... Journal of clinical microbiology 59 (3), 10.1128/jcm. 02314-20, 2021 | 84 | 2021 |
| Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables P Kambli, K Ajbani, C Nikam, M Sadani, A Shetty, Z Udwadia, ... The International Journal of Mycobacteriology 5 (1), 1-6, 2016 | 74 | 2016 |
| Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic … A Penn-Nicholson, SB Georghiou, N Ciobanu, M Kazi, M Bhalla, A David, ... The Lancet Infectious Diseases 22 (2), 242-249, 2022 | 69 | 2022 |
| Performance comparison of three rapid tests for the diagnosis of drug-resistant tuberculosis A Catanzaro, TC Rodwell, DG Catanzaro, RS Garfein, RL Jackson, ... PloS one 10 (8), e0136861, 2015 | 51 | 2015 |
| Tuberculosis treatment monitoring and outcome measures: new interest and new strategies J Heyckendorf, SB Georghiou, N Frahm, N Heinrich, I Kontsevaya, ... Clinical microbiology reviews 35 (3), e00227-21, 2022 | 46 | 2022 |
| Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrations P Kambli, K Ajbani, M Sadani, C Nikam, A Shetty, Z Udwadia, ... Diagnostic microbiology and infectious disease 82 (1), 49-53, 2015 | 41 | 2015 |
| Frequency and distribution of tuberculosis resistance-associated mutations between Mumbai, Moldova, and Eastern Cape SB Georghiou, M Seifert, D Catanzaro, RS Garfein, F Valafar, V Crudu, ... Antimicrobial agents and chemotherapy 60 (7), 3994-4004, 2016 | 35 | 2016 |
| On the consequences of poorly defined breakpoints for rifampin susceptibility testing of Mycobacterium tuberculosis complex CU Köser, SB Georghiou, T Schön, M Salfinger Journal of Clinical Microbiology 59 (4), 10.1128/jcm. 02328-20, 2021 | 31 | 2021 |
| MTBDRplus and MTBDRsl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis M Seifert, SB Georghiou, D Catanzaro, C Rodrigues, V Crudu, TC Victor, ... Journal of clinical microbiology 54 (4), 912-918, 2016 | 27 | 2016 |
| A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis M Seifert, K Ajbani, SB Georghiou, D Catanzaro, C Rodrigues, V Crudu, ... The international journal of tuberculosis and lung disease 20 (5), 631-637, 2016 | 24 | 2016 |
| Comparative analytical evaluation of four centralized platforms for the detection of Mycobacterium tuberculosis complex and resistance to rifampicin and isoniazid M de Vos, L Scott, A David, A Trollip, H Hoffmann, S Georghiou, ... Journal of Clinical Microbiology 59 (3), 10.1128/jcm. 02168-20, 2021 | 21 | 2021 |
| What is the role of the EUCAST reference method for MIC testing of the Mycobacterium tuberculosis complex? T Schön, CU Köser, J Werngren, M Viveiros, S Georghiou, G Kahlmeter, ... Clinical microbiology and infection 26 (11), 1453-1455, 2020 | 20 | 2020 |
| Redefining MTBDRplus test results: what do indeterminate results actually mean? C Nikam, R Patel, M Sadani, K Ajbani, M Kazi, R Soman, A Shetty, ... The International Journal of Tuberculosis and Lung Disease 20 (2), 154-159, 2016 | 20 | 2016 |
| Increased tuberculosis patient mortality associated with Mycobacterium tuberculosis mutations conferring resistance to second-line antituberculous drugs SB Georghiou, M Seifert, DG Catanzaro, RS Garfein, TC Rodwell Journal of Clinical Microbiology 55 (6), 1928-1937, 2017 | 19 | 2017 |
| Analytical performance of the Xpert MTB/XDR® assay for tuberculosis and expanded resistance detection SB Georghiou, A Penn-Nicholson, M de Vos, A Macé, MW Syrmis, ... Diagnostic microbiology and infectious disease 101 (1), 115397, 2021 | 18 | 2021 |
| Impact of fluoroquinolone use on mortality among a cohort of patients with suspected drug-resistant tuberculosis M Seifert, SB Georghiou, RS Garfein, D Catanzaro, TC Rodwell Clinical Infectious Diseases 65 (5), 772-778, 2017 | 18 | 2017 |
| Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis SB Georghiou, M Seifert, SY Lin, D Catanzaro, RS Garfein, RL Jackson, ... BMC infectious diseases 16, 1-11, 2016 | 16 | 2016 |
